Comparing hypnosis and standard care for treating non-REM parasomnias
Evaluation of the Efficacy of Non-pharmacological Treatments for Parasomnias: a Randomized Controlled Trial
This study is testing whether medical hypnosis can help people with non-REM sleep disorders feel better compared to standard treatment methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre de Médecine Intégrative et Complémentaire (CEMIC) Academic / other |
| Locations | 1 site (Lausanne, Vaud) |
| Trial ID | NCT05953207 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of non-pharmacological treatments, specifically medical hypnosis, compared to standard treatment methods for patients diagnosed with non-REM parasomnia. Participants will be randomly assigned to receive either medical hypnosis or standard care, which includes sleep hygiene and risk reduction strategies. The study involves a total of five visits, including treatment sessions and assessments to monitor sleep patterns and treatment outcomes through questionnaires and electroencephalography.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with non-REM parasomnia who experience at least one episode per month.
Not a fit: Patients with significant comorbid conditions affecting sleep or those currently taking medications that interfere with sleep architecture may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel, non-drug approach to effectively manage non-REM parasomnias.
How similar studies have performed: While the use of hypnosis in treating sleep disorders is explored, this specific comparison of hypnosis and standard care for non-REM parasomnias is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non-REM parasomnias diagnosis according to the international classification disease of sleep disorders * Willling and able to give informed consent * Reporting at least one parasomniac episode per month * Reporting at least one parasomniac episode the month prior Exclusion Criteria: * Refusal to use the home video recording device * Current or planned intake (during the next 2 months) of medications/substances that may interfere with sleep architecture (e.g., hypnotics, neuroleptics, antidepressants, benzodiazepines) * A comorbid significant somatic disease altering the brain (e.g., cancer, epilepsy, multiple sclerosis, dementia) * A comorbid sleep disorder (e.g., apnea-hypopnea index (AHI) \>= 20/hour, REM sleep behaviour disorder, restless legs syndrome with symptoms more than 2 days/week) * A comorbid psychiatric disorder (e.g., severe depressive or anxiety disorder or psychotic disorder)
Where this trial is running
Lausanne, Vaud
- Centre hospitalier universitaire vaudois (CHUV) — Lausanne, Vaud, Switzerland (Recruiting)
Study contacts
- Principal investigator: Chantal Berna Renella, Prof — Chuv
- Study coordinator: Geoffroy Solelhac, Dr.
- Email: geoffroy.solelhac@chuv.ch
- Phone: +41 79 556 34 48
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.